Olainfarm
JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on March 2, 2020 at 04:00 PM (EET). To join the webinar please follow the instructions below.
Webinar will be hosted by the Chairman of Management Board Jeroen Weites and member of the management board Zane Kotāne. The presentation will be held in English.
During the webinar JSC Olainfarm representatives will inform about the recent performance of the company and financial results of fourth quarter of 2020 and 12 months of 2020.
After the presentation investors are welcome to ask questions. Due to the limited webinar time please send in your questions until March 1 to e-mail: marta.muizniece@nasdaq.com.
What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.
How to join the webinar?
All you need is a computer with internet connection and headphones.
To join the webinar, we invite you to register via https://attendee.gotowebinar.com/register/8963245590784457998
You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.
Join the webinar and be the first one to hear the news!
JSC Olainfarm, a part of Olainfarm Group, is one of the leading pharmaceutical companies in the Baltic States offering high quality medicine and chemical pharmaceutical products. The Group’s business strategy "FORWARD" highlights the company’s main vision – to become one of the TOP10 Central and Eastern European manufacturing companies by 2025.
With nearly 50 years of expertise, Olainfarm Group delivers sustainable healthcare products and services with added value to patients in more than 50 countries all over the world via its key subsidiaries – pharmaceutical company JSC Olainfarm, food supplement & medical device provider Silvanols, elastic & compression material producer Tonus Elast, pharmacy chain Latvijas Aptieka and healthcare & diagnostics centres DiaMed & OlainMed.
Additional information:
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Nykredit Realkredit A/S2.7.2025 14:10:29 CEST | Pressemeddelelse
Nykredit Realkredit A/S: Ledende medarbejdere og disses nærtstående transaktioner
Purdue Research Foundation2.7.2025 14:03:26 CEST | Press release
Purdue Research Foundation and Archaeological Legacy Institute to embark on expedition to identify Amelia Earhart’s missing plane
VCI Global Limited2.7.2025 13:30:00 CEST | Press release
QuantGold Launches Qsecore: World’s First SIM-Layer Encryption Platform for Mobile Security
DeFi Technologies Inc.2.7.2025 13:30:00 CEST | Press release
Valour Launches Eight New ETPs on Spotlight Stock Market, Including Bitcoin Cash (BCH), Unus Sed Leo (LEO), OKB (OKB), Polygon (POL), Algorand (ALGO), Filecoin (FIL), Arbitrum (ARB), and Stacks (STX)
ZenaTech Inc.2.7.2025 13:30:00 CEST | Press release
ZenaTech Expands Drone as a Service (DaaS) to California with Offer to Acquire an Engineering and Surveying Firm, Tapping into Precision Agriculture and Viticulture Market
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom